Corrigendum to “Dual Drug Delivery System of Plga Nanoparticles to Reverse Drug Resistance by Altering Bax/Bcl-2” [J. Drug Deliv. Sci. Technol. 47 (2018) 291–298, (S1773224718301825), (10.1016/J.Jddst.2018.07.019)]

Corrigendum to “Dual Drug Delivery System of Plga Nanoparticles to Reverse Drug Resistance by Altering Bax/Bcl-2” [J. Drug Deliv. Sci. Technol. 47 (2018) 291–298, (S1773224718301825), (10.1016/J.Jddst.2018.07.019)] Publisher

Alvandifar F¹ ; Ghaffari B² ; Goodarzi N¹ ; Ravari NS¹ ; Karami F¹ ; Amini M⁴ ; Souri E⁴ ; Khoshayand MR⁵ ; Esfandyarimanesh M¹ ; Jafari RM⁶ ; Atyabi F^{1, 3} ; Irani S² ; Dinarvand R^{1, 3}

Show Affiliations

1. Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, 1417614411, Iran
2. Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran
3. Nanomedicine and Biomaterial Lab, Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
4. Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
5. Department of Drug and Food Control, Faculty of Pharmacy and Pharmaceutical Quality Assurance Research Center, Tehran University of Medical Sciences, Tehran, Iran
6. Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Drug Delivery Science and Technology Published:2023

Abstract

The authors regret that Figs. 3a and b are not correct. It must be replaced by the following Fig. 3.[Formula presented] Fig. 3. Particle size and distribution of optimized nanoparticles measured by DLS method (a), and morphology and surface characteristics of optimized nanoparticles evaluated with SEM (b) and AFM (c). This correction does not change the discussion or conclusions of the article. The authors would like to apologize for any inconvenience caused. © 2023 Elsevier B.V.

Style	Citing Format
MLA	Alvandifar F, et al.. "Corrigendum to “Dual Drug Delivery System of Plga Nanoparticles to Reverse Drug Resistance by Altering Bax/Bcl-2” [J. Drug Deliv. Sci. Technol. 47 (2018) 291–298, (S1773224718301825), (10.1016/J.Jddst.2018.07.019)]." Journal of Drug Delivery Science and Technology, vol. 81, no. , 2023, pp. -.
APA	Alvandifar F, Ghaffari B, Goodarzi N, Ravari NS, Karami F, Amini M, Souri E, Khoshayand MR, Esfandyarimanesh M, Jafari RM, Atyabi F, Irani S, Dinarvand R (2023). Corrigendum to “Dual Drug Delivery System of Plga Nanoparticles to Reverse Drug Resistance by Altering Bax/Bcl-2” [J. Drug Deliv. Sci. Technol. 47 (2018) 291–298, (S1773224718301825), (10.1016/J.Jddst.2018.07.019)]. Journal of Drug Delivery Science and Technology, 81(), -.
Chicago	Alvandifar F, Ghaffari B, Goodarzi N, Ravari NS, Karami F, Amini M, Souri E, et al.. "Corrigendum to “Dual Drug Delivery System of Plga Nanoparticles to Reverse Drug Resistance by Altering Bax/Bcl-2” [J. Drug Deliv. Sci. Technol. 47 (2018) 291–298, (S1773224718301825), (10.1016/J.Jddst.2018.07.019)]." Journal of Drug Delivery Science and Technology 81, no. (2023): -.
Harvard	Alvandifar F et al. (2023) 'Corrigendum to “Dual Drug Delivery System of Plga Nanoparticles to Reverse Drug Resistance by Altering Bax/Bcl-2” [J. Drug Deliv. Sci. Technol. 47 (2018) 291–298, (S1773224718301825), (10.1016/J.Jddst.2018.07.019)]', Journal of Drug Delivery Science and Technology, 81(), pp. -.
Vancouver	Alvandifar F, Ghaffari B, Goodarzi N, Ravari NS, Karami F, Amini M, et al.. Corrigendum to “Dual Drug Delivery System of Plga Nanoparticles to Reverse Drug Resistance by Altering Bax/Bcl-2” [J. Drug Deliv. Sci. Technol. 47 (2018) 291–298, (S1773224718301825), (10.1016/J.Jddst.2018.07.019)]. Journal of Drug Delivery Science and Technology. 2023;81():-.
BibTex	@article{ author = {Alvandifar F and Ghaffari B and Goodarzi N and Ravari NS and Karami F and Amini M and Souri E and Khoshayand MR and Esfandyarimanesh M and Jafari RM and Atyabi F and Irani S and Dinarvand R}, title = {Corrigendum to “Dual Drug Delivery System of Plga Nanoparticles to Reverse Drug Resistance by Altering Bax/Bcl-2” [J. Drug Deliv. Sci. Technol. 47 (2018) 291–298, (S1773224718301825), (10.1016/J.Jddst.2018.07.019)]}, journal = {Journal of Drug Delivery Science and Technology}, volume = {81}, number = {}, pages = {-}, year = {2023} }
RIS	TY - JOUR AU - Alvandifar F AU - Ghaffari B AU - Goodarzi N AU - Ravari NS AU - Karami F AU - Amini M AU - Souri E AU - Khoshayand MR AU - Esfandyarimanesh M AU - Jafari RM AU - Atyabi F AU - Irani S AU - Dinarvand R TI - Corrigendum to “Dual Drug Delivery System of Plga Nanoparticles to Reverse Drug Resistance by Altering Bax/Bcl-2” [J. Drug Deliv. Sci. Technol. 47 (2018) 291–298, (S1773224718301825), (10.1016/J.Jddst.2018.07.019)] JO - Journal of Drug Delivery Science and Technology VL - 81 IS - SP - EP - PY - 2023 ER -

Style

Citing Format

MLA

Alvandifar F, et al.. "Corrigendum to “Dual Drug Delivery System of Plga Nanoparticles to Reverse Drug Resistance by Altering Bax/Bcl-2” [J. Drug Deliv. Sci. Technol. 47 (2018) 291–298, (S1773224718301825), (10.1016/J.Jddst.2018.07.019)]." Journal of Drug Delivery Science and Technology, vol. 81, no. , 2023, pp. -.

APA

Alvandifar F, Ghaffari B, Goodarzi N, Ravari NS, Karami F, Amini M, Souri E, Khoshayand MR, Esfandyarimanesh M, Jafari RM, Atyabi F, Irani S, Dinarvand R (2023). Corrigendum to “Dual Drug Delivery System of Plga Nanoparticles to Reverse Drug Resistance by Altering Bax/Bcl-2” [J. Drug Deliv. Sci. Technol. 47 (2018) 291–298, (S1773224718301825), (10.1016/J.Jddst.2018.07.019)]. Journal of Drug Delivery Science and Technology, 81(), -.

Chicago

Alvandifar F, Ghaffari B, Goodarzi N, Ravari NS, Karami F, Amini M, Souri E, et al.. "Corrigendum to “Dual Drug Delivery System of Plga Nanoparticles to Reverse Drug Resistance by Altering Bax/Bcl-2” [J. Drug Deliv. Sci. Technol. 47 (2018) 291–298, (S1773224718301825), (10.1016/J.Jddst.2018.07.019)]." Journal of Drug Delivery Science and Technology 81, no. (2023): -.

Harvard

Alvandifar F et al. (2023) 'Corrigendum to “Dual Drug Delivery System of Plga Nanoparticles to Reverse Drug Resistance by Altering Bax/Bcl-2” [J. Drug Deliv. Sci. Technol. 47 (2018) 291–298, (S1773224718301825), (10.1016/J.Jddst.2018.07.019)]', Journal of Drug Delivery Science and Technology, 81(), pp. -.

Vancouver

Alvandifar F, Ghaffari B, Goodarzi N, Ravari NS, Karami F, Amini M, et al.. Corrigendum to “Dual Drug Delivery System of Plga Nanoparticles to Reverse Drug Resistance by Altering Bax/Bcl-2” [J. Drug Deliv. Sci. Technol. 47 (2018) 291–298, (S1773224718301825), (10.1016/J.Jddst.2018.07.019)]. Journal of Drug Delivery Science and Technology. 2023;81():-.

BibTex

@article{ author = {Alvandifar F and Ghaffari B and Goodarzi N and Ravari NS and Karami F and Amini M and Souri E and Khoshayand MR and Esfandyarimanesh M and Jafari RM and Atyabi F and Irani S and Dinarvand R}, title = {Corrigendum to “Dual Drug Delivery System of Plga Nanoparticles to Reverse Drug Resistance by Altering Bax/Bcl-2” [J. Drug Deliv. Sci. Technol. 47 (2018) 291–298, (S1773224718301825), (10.1016/J.Jddst.2018.07.019)]}, journal = {Journal of Drug Delivery Science and Technology}, volume = {81}, number = {}, pages = {-}, year = {2023} }

RIS

TY - JOUR
AU - Alvandifar F
AU - Ghaffari B
AU - Goodarzi N
AU - Ravari NS
AU - Karami F
AU - Amini M
AU - Souri E
AU - Khoshayand MR
AU - Esfandyarimanesh M
AU - Jafari RM
AU - Atyabi F
AU - Irani S
AU - Dinarvand R
TI - Corrigendum to “Dual Drug Delivery System of Plga Nanoparticles to Reverse Drug Resistance by Altering Bax/Bcl-2” [J. Drug Deliv. Sci. Technol. 47 (2018) 291–298, (S1773224718301825), (10.1016/J.Jddst.2018.07.019)]
JO - Journal of Drug Delivery Science and Technology
VL - 81
IS -
SP -
EP -
PY - 2023
ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract